Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
Cyber security is a top compliance concern according to a survey of compliance professionals conducted by Health Care Compliance Association (HCCA) and the…
From - G2 Compliance Advisor
Once again, payments to physicians to induce referrals of lab tests has led to government enforcement efforts—but this time…
From - G2 Compliance Advisor
Labs and other providers are required by a provision enacted in the Affordable Care Act to return to Medicare overpayments within 60 days of…